Showing posts with label Olympus Corporation. Show all posts
Showing posts with label Olympus Corporation. Show all posts

Tuesday 13 November 2018

Endoscopes Market Expected To Trigger A Revenue Increase To 17.19 Billion By 2025:Key Participant Olympus Corporation, Ethicon US


San Francisco, 12 November 2018 , The global endoscopes market size is expected to reach USD 17.19 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 8.8% during the forecast period. Growing global geriatric population, high prevalence of gastrointestinal diseases, and rising technological advancements are the key factors contributing to market growth. Rising preference for minimally invasive surgeries (MIS) is also positively influencing the growth of the market.
Endoscopy surgeries are performed for diagnosis as well as treatment of gastrointestinal, gynecological, neurological, and cardiovascular diseases. Emergence of minimally invasive alternatives to open surgeries such as laparoscopy, hysteroscopy, and colonoscopy is boosting the demand for endoscopes. Preference of MIS is increasing owing to smaller incision, reduction in postoperative complications & mortality, and lesser trauma. Furthermore, they are economically viable alternatives to open surgeries.
Availability of technologically advanced endoscopes is also providing a significant push to the market. Market players are undertaking R&D initiatives to improve existing products as well as launch new products, which is expected to bolster the growth of the market. For example, VISERA 4K UHD System is a surgical system lunched by Olympus in 2016 with 55-inch primary operative display for enhancing MIS.
In March 2018, Auris Health, Inc. announced FDA approval of its new robotic endoscopy system, Monarch Platform. In June 2017, Olympus launched 3D surgical endoscope designed to be compatible with VISERA ELITE II system. It uses 3D imaging facilitating depth perception that enables precise surgery. Pentax Medical launched Slim Linear Ultrasound Endoscope (EG-3270UK) in the U.S. in August 2017.
Full Research Report On Endoscopes Market Analysis:
www.grandviewresearch.com/industry-analysis/endoscopes-market

Further key findings from the report suggest:
·         Flexible endoscopes emerged as the largest product segment in 2017, accounting for more than half of the market revenue
·         Gastrointestinal endoscopy was the leading revenue contributor in the market, on the basis of applications, in 2017. On the other hand, urology endoscopy is expected to emerge as the fastest growing segment over the forecast period
·         Hospitals was the largest end-use segment in 2018 in terms of revenue. Ambulatory surgery centers are rapidly gaining popularity and the segment is anticipated to register the highest CAGR during the same period
·         North America was the dominant regional market in 2017 due to high healthcare expenditure, favorable reimbursement framework, growing elderly population and disease burden, and heightened adoption of technologically advanced products
·         Asia Pacific is likely to exhibit a lucrative CAGR of 10.6% during the forecast period owing to economic development in emerging countries, improvement in healthcare infrastructure, and increase in awareness about MIS
·         Olympus Corporation; Ethicon US, LLC; Fujifilm Holdings Corporation; Boston Scientific Corporation; Karl Storz GmbH & Co. KG; Stryker; Medtronic; and CONMED Corporation are the leading players in the endoscopes market.
Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global endoscopes market on the basis of product, applications, end use, and region:
Endoscopes Product Outlook (Revenue, USD Million, 2014 - 2025)
·         Rigid Endoscopes
o    Laparoscopes
o    Arthroscopes
o    Urology endoscopes
o    Cystoscopes
o    Gynecology endoscopes
o    Neuroendoscopes
o    Other rigid endoscopes
·         Flexible Endoscopes
o    Upper gastrointestinal endoscopes
o    Colonoscopes
o    Bronchoscopes
o    Sigmoidoscopes
o    Laryngoscopes
o    Pharyngoscopes
o    Duodenoscopes
o    Nasopharyngoscopes
o    Rhinoscopes
o    Other flexible endoscopes
·         Capsule Endoscopes
·         Disposable Endoscopes
·         Robot Assisted Endoscopes
Endoscopes Application Outlook (Revenue, USD Million, 2014 - 2025)
·         Gastrointestinal (GI) endoscopy
·         Urology endoscopy (cystoscopy)
·         Laparoscopy
·         Obstetrics/gynecology endoscopy
·         Arthroscopy
·         Bronchoscopy
·         Mediastinoscopy
·         Otoscopy
·         Laryngoscopy
·         Other applications
Endoscopes End Use Outlook (Revenue, USD Million, 2014 - 2025)
·         Hospitals
·         Ambulatory surgery centers
·         Other End Uses
Endoscopes Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    U.K.
o    France
o    Russia
o    Italy
o    Spain
o    Denmark
o    Switzerland
·         Asia Pacific
o    China
o    Japan
o    India
o    Australia
o    New Zealand
o    Thailand
o    Indonesia
o    Malaysia
o    Vietnam
o    Philippines
·         Latin America
o    Brazil
o    Mexico
o    Argentina
·         Middle East & Africa
o    South Africa
o    Saudi Arabia
o    Israel
o    U.A.E.
o    Kuwait

Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-endoscopes-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/

Thursday 4 October 2018

Neuroendoscopy Devicess Market Expected To Trigger A Revenue Increase To USD 203.9 Million By 2025:Key Participant B. Braun Medical Inc., Karl Storz


According to a report published by Grand View Research, Inc.; the Neuroendoscopy Devices Market is likely to reach a valuation of around USD 203.9 million by 2025.
Increasing cases of brain injuries and neural surgeries, and high demand for minimally invasive surgeries can propel the market over the forecast period (2014 to 2025). Additionally, increasing efforts from the government and private institutions to support the acceptance of neuroendoscopy and growing investments for research and development activities by the major players are expected to create positive outlook for the market.

Full Research Report On Neuroendoscopy Devices Market  Analysis: www.grandviewresearch.com/industry-analysis/neuroendoscopy-market


Conventional brain surgeries like craniotomy are mostly invasive and complex which involves complete opening of skull. These surgical procedures involve high risk of stroke or hemorrhage, deafness, blindness, and death in several cases. These conditions can be avoided by adopting minimally invasive procedures. Therefore, use of neuroendoscopy is increasing constantly. These devises are extensively used in the treatment of intraventricular hemorrhage and bleeding, hydrocephalus, and pituitary tumors. Thus, continuous rise in cases of pituitary tumors and intraventricular hemorrhage are likely to support the market growth in the coming years.
Worldwide neuroendoscopy devices market can be segmented on the basis of devices type, surgery, type, application, and region.

Browse More Reports Of This Category By Grand View Research At: www.grandviewresearch.com/industry/medical-devices

Based on devices type, the market can be classified into rigid and flexible.
Rigid segment is expected to show high growth in the years to come. Rigid neuroendoscopes are extensively used to treat disorders including hydrocephalus, intraventricular tumors, and cystic lesions. As per Hydrocephalus Association U.S., one to two of every 1000 babies born are diagnose with hydrocephalus. Therefore, high prevalence of these disorders is expected to drive the segment growth. These devices are available in light weight versions, therefore have high demand in interventricular surgeries. 

As per surgery type, the market can be bifurcated into intraventricular, transcranial, and transnasal. In 2016, Intraventricular segment estimated for the major revenue share owing to high prevalence of the intraventricular hemorrhage and bleeding. The, transcranial surgery segment is likely to display rapid growth during the forecast period due to technological developments and growing cases of pituitary gland tumors. On the basis of application, the market can be categorized into hospitals and medical research centers.

In 2016, the hospitals segment acquired the largest market share and likely to continue this trend over the forecast period. Several benefits offered by neuroendoscopy such as exact access at target site that is situated in the interior parts of brain and minimal incision have forced hospitals to adopt this procedure. Moreover, hospitals have reported the high number of neuro-endoscopic procedures due to availability of established healthcare facilities in case of emergencies and presence of skilled health care specialist and neurosurgeons.

Geographically, the market can be divided into North America, Europe, Asia Pacific, Latin America, and MEA. North America is largest markets followed by the Europe. In 2016, these regions collectively acquired the major market share due to availability of advanced healthcare infrastructure and high use of advanced techniques, which has lead to high adoption of neuroendoscopy. In addition, technological developments in the healthcare and high prevalence of pituitary tumors are supporting the market growth in these regions. The U.S is considered as the major market for neuroendoscopy across the globe. Fast recovery of patients operated with minimally invasive procedure offered by these devices has increased the popularity of these devices in the country.

Asia Pacific market is expected to show rapid growth during the forecast period due to presence of unexploited growth opportunities in the region. Countries such as India, China and Japan have huge opportunities. Factors such as enforced healthcare insurance, growing technological advancements, and growing healthcare spending are expected to boost the market growth in this region.
Key companies operating in the market include B. Braun Medical Inc.; Olympus Corporation; Stryker, Medtronic; and Karl Storz. Major participants in the market are trying to strengthen their position in the market by adopting strategies like mergers and acquisitions, and strategic alliances.


About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/


Thursday 20 September 2018

SmartPill - The Future of Health Care is Here


According to a research report published by Grand View Research, Inc.; the Smart Pills Market likely to reach a valuation of around USD 3.0 billion by 2025. The market is estimated to register a healthy growth rate of 15.5 % during the forecast period (from 2018 to 2025). High prevalence of gastrointestinal disorders and colorectal cancer is one of the primary factors responsible for the increased demand for smart pills. Moreover, rise in cancer screening awareness programs and increasing FDA approvals are also considered as the major factors driving the market growth.
Smart pills are mainly used for screening and treatment of various diseases including colorectal cancer, gastroparesis, gastric ulcers, gastroesophageal disorders. They also find applications in the treatment of several GI-related diseases including Crohn’s disease, celiac disease, small bowel tumors, and obscure GI bleed. These pills provide non-invasive and accurate visualization of the distal duodenum, small bowel, jejunum, colon, ileum, and gastrointestinal.
Full Research Report On Smart Pills Market Analysis: www.grandviewresearch.com/industry-analysis/smart-pills-market
Increasing demand for minimally invasive surgical procedures have encourage the development of innovative methods like capsule endoscopy. This is likely to replace the traditional method of endoscopy, thereby driving the smart pills market growth in the next few years. In addition, patients suffering from chronic diseases require a particular dose of medicines at target place. This is also anticipated to create a large consumer base for advanced drug delivery aids, thereby augmenting the market growth.
Demand for advanced drug delivery systems with benefits including optimal use of active pharmaceutical constituent, negligible side effects, reduced dosage frequency, and harmless carrier is also likely to fuel product demand. Worldwide smart pills market is segmented into application and region. Based on application, the market is categorized into product, tools, and patient monitoring software. Geographically, the market is divided into North America; Europe, Asia Pacific, Latin America, and Middle East and Africa (MEA).
Browse More Reports Of This Category By Grand View Research At: www.grandviewresearch.com/industry/medical-devices
In 2016, North America accounted for the largest revenue share of 57.1 % and dominated the global market in the past. It is expected to maintain its dominance even during the forecast period. Factors such as growing government expenditure for healthcare, favorable reimbursement policies, and technological progressions are projected to be the major drivers for the region’s expansion. In addition, mandatory healthcare insurance, rising cases of colorectal cancer, and approvals for newer products are also likely to propel the market development in the region.
Asia Pacific is likely to witness the fastest growth over the next few years. Emerging countries in this region such as India, Japan, and China are expected to drive the product demand. Among these Asian countries, Japan stands on third position in stomach cancer cases, according to the World Cancer Research Fund International. Rapidly expanding Japanese market is mainly driven by high prevalence of stomach cancer and cases of gastrointestinal complaints. Moreover, growing government support and technological developments would also spur the regional expansion.
Some of the leading companies operating in the global market for smart pills include CapsoVision, Inc.; Olympus Corporation; Medtronic PLC; MediSafe; and Proteus Digital Health. Most of these major market participants are mainly focusing on upgrading their products. The new participants focus on developing more advanced and affordable products. For instance, Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Proteus Digital Health (Proteus) recently declared that they received an approval from the US Food and Drug Administration (FDA) for their digital medicine system called ABILIFY MYCITE. It is a drug-device combination product that contains Otsuka’s oral aripiprazole tablets implanted with an Ingestible Event Marker (IEM) sensor.
ABILIFY MYCITE is designed to track drug ingestion. The new ABILIFY MYCITE is an atypical antipsychotic and is indicated in adults to treat schizophrenia and acute manic and mixed episodes and for maintaining the treatment of bipolar I disorder as monotherapy and as adjunctive therapy to lithium or valproate. However, it is recommended not to use the new product to track drug ingestion in real-time or during an emergency as detection may be delayed or may not occur.

Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-smart-pills-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com